CALM1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.515000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.930600E-01
Normal-vs-Stage2
7.870200E-01
Normal-vs-Stage3
3.631200E-01
Normal-vs-Stage4
8.214000E-01
Stage1-vs-Stage2
3.400000E-01
Stage1-vs-Stage3
2.150600E-01
Stage1-vs-Stage4
9.160600E-01
Stage2-vs-Stage3
3.977600E-01
Stage2-vs-Stage4
5.233600E-01
Stage3-vs-Stage4
3.526400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.244400E-01
Normal-vs-AfricanAmerican
6.406000E-01
Normal-vs-Asian
6.516400E-01
Caucasian-vs-AfricanAmerican
5.929200E-01
Caucasian-vs-Asian
4.093800E-01
AfricanAmerican-vs-Asian
9.217400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.978800E-01
Normal-vs-Female
8.903800E-01
Male-vs-Female
5.959000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.011800E-01
Normal-vs-Age(41-60Yrs)
6.495000E-01
Normal-vs-Age(61-80Yrs)
9.443600E-01
Normal-vs-Age(81-100Yrs)
1.692790E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.137000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.936200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.707800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.428100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.220600E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.042750E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.500000E-01
Normal-vs-Daily Drinker
8.734200E-01
Normal-vs-Weekly Drinker
4.840000E-01
Normal-vs-Occasional Drinker
2.420600E-01
Normal-vs-Social Drinker
7.520000E-01
Non Drinker-vs-Daily Drinker
2.163600E-01
Non Drinker-vs-Weekly Drinker
6.429600E-01
Non Drinker-vs-Occasional Drinker
6.913700E-02
Non Drinker-vs-Social Drinker
1.163170E-01
Daily Drinker-vs-Weekly Drinker
5.285600E-01
Daily Drinker-vs-Occasional Drinker
1.942760E-01
Daily Drinker-vs-Social Drinker
3.583200E-01
Weekly Drinker-vs-Occasional Drinker
1.038420E-01
Weekly Drinker-vs-Social Drinker
1.954560E-01
Occasional Drinker-vs-Social Drinker
5.716800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.655200E-01
Normal-vs-Grade 2
4.042500E-02
Normal-vs-Grade 3
6.912400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.574400E-02
Grade 1-vs-Grade 3
2.123500E-02
Grade 1-vs-Grade 4
2.655200E-01
Grade 2-vs-Grade 3
1.117370E-01
Grade 2-vs-Grade 4
4.042500E-02
Grade 3-vs-Grade 4
6.912400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.109800E-01
Normal-vs-NonDiabetic
9.412400E-01
Diabetic-vs-NonDiabetic
3.360800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.746800E-01
Normal-vs-NoPancreatitis
9.625400E-01
Pancreatitis-vs-NoPancreatitis
3.152000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.961400E-01
Normal-vs-N1
8.230200E-01
N0-vs-N1
1.773750E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.211000E-01
Normal-vs-TP53-NonMutant
2.085400E-01
TP53-Mutant-vs-TP53-NonMutant
5.151800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
